Transfection of miR-196a inhibitor increased proliferation and migration and prevented apoptosis of SCC9 oral cancer cells by inhibiting phosphorylation of PI3K and AKT and enhancing FOXO1 levels. Here, AKT1 is linked to lip and oral cavity carcinoma.